{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:42:55Z","timestamp":1782963775727,"version":"3.54.5"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1365-2230.2009.03427.x","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T19:23:54Z","timestamp":1246908234000},"page":"251-256","source":"Crossref","is-referenced-by-count":39,"title":["A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial"],"prefix":"10.1093","volume":"35","author":[{"given":"R.","family":"Koca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Altinyazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ankarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e.","family":"Muhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"\u00c7inar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB2","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea. Pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB5","first-page":"1","article-title":"Systemic therapy for rosacea","volume":"12","author":"Baldwin","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archderm.1994.01690030051008","article-title":"A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea","volume":"130","author":"Ertl","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1468-3083.2003.00692.x","article-title":"Pimecrolimus: a review","volume":"17","author":"Gupta","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00015550510043975","article-title":"Pimecrolimus cream 1% is effective in a case of granulomatous rosacea","volume":"86","author":"Cunha","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-9740.2005.03740.x","article-title":"Pimecrolimus for treatment of acne rosacea","volume":"4","author":"Crawford","year":"2005","journal-title":"Skinmed"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","article-title":"The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea","volume":"152","author":"Chu","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-3083.2006.01991.x","article-title":"An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption","volume":"21","author":"Chu","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00128071-200001030-00007","article-title":"Topical metronidazole. A review of its use in rosacea","volume":"1","author":"McClellan","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1986.tb02802.x","article-title":"Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea","volume":"114","author":"Miyachi","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1365-2133.2001.04134.x","article-title":"SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis","volume":"144","author":"Luger","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2005.04.053","article-title":"Rosaceiform eruption to pimecrolimus","volume":"54","author":"El Sayed","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archderm.141.9.1168","article-title":"Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream","volume":"141","author":"Gorman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000071800","article-title":"Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream","volume":"207","author":"Lubbe","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2230.2009.03427.x-BIB23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-4632.2007.03325.x","article-title":"Pimecrolimus-induced rosacea-like demodicidosis","volume":"46","author":"Yoon","year":"2007","journal-title":"Int J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03427.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03427.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T22:10:28Z","timestamp":1710454228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/3\/251\/6622309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03427.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718430986.793495895","asserted-by":"object"}]},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}